Blog

[U2Q] Nia has been taking increasing doses of an SSRI with a long half-life for several weeks. In an effort to produce an improved therapeutic effect, her doctor prescribes her a high dose of a different SSRI with a much shorter half-life. Nia begins to display signs of EPS, some agitation, and even disorientation. Nia is probably showing signs of:

[U3Q]  Doctors often start a psychotropic medication on a low dose and increase the dosage level step-by-step as needed. What effect listed below is NOT likely to result from following this type of protocol?

[U3Q]  James is working with a client on Abilify. He has spoken with the prescriber to identify some key side effects to train staff on, but he would like some more information on this drug’s side effects. Which of the following resources would be most helpful?

[U2Q] After Vince starts a regimen of antipsychotics, his friends comment to him that they notice he is moving his hands and legs around in a very restless manner. Vince might be experiencing which of the following as the result of the medication?

[U2Q] The first-generation type of antidepressants are called:

[U1Q] In behavioral pharmacology, the term “excretion” refers: 

[FinB] ______ tolerance is when a person learns to function more effectively under the influence of the drug.

[U1Q] What is the primary measurement target for a dose-response curve?     

[U1Q] The primary site of action for most substances used in behavioral pharmacology is the: 

[U3Q]  Which variation of a parametric analysis of a drug is a prescriber most likely to agree to do?